John F. DiPersio Lab

#Immunotherapeutics for #hememalignancy. Stem cell mobilization. #CARTcell #GvHD #CRISPR #CytokineReleaseSyndrome @wustlmed @sitemancenter

[John F. DiPersio Lab @DiPersioLab]

DiPersio’s Altered Career Path Led to Groundbreaking Developments in Leukemia https://t.co/dpgZh8jyGQ via @onclive

[John F. DiPersio Lab @DiPersioLab]

DiPersio recognized for discoveries in cancer biology https://t.co/YbWBT1DgJm

[John F. DiPersio Lab @DiPersioLab]

Check out my podcast on vjhemonc!
https://t.co/7NBObv3hd9

[John F. DiPersio Lab @DiPersioLab]

Congratulations, Steve, on the final publication. You took the lead on this project and I, like you, hope it will have a transformative effect on improving the safety of patient transplants in the future.

[John F. DiPersio Lab @DiPersioLab]

So happy to be at an in person meeting! #ASH21 #GvHD #CARTcells #leukemia

[WashU Medicine Division of Physician-Scientists @WashUDPS]

Great things happening!! @WUSTLmed @SitemanCenter @DiPersioLab

[John F. DiPersio Lab @DiPersioLab]

A summary of the new developments in treating #GVHD discussed at #ASH21.

https://t.co/OJQbcQQflu

[John F. DiPersio Lab @DiPersioLab]

More hope for preventing chronic #GvHD! Small prophylactic trial in patients using belimumab, an antibody against BAFF, to keep from activating the B cells. Early results suggest it may help!

https://t.co/5acbEnMSQO

[John F. DiPersio Lab @DiPersioLab]

Mobilizing stem cells in #myeloma patients with motixafortide (BL8040).
#hememalignancies

https://t.co/uw6mDjNLIC

[John F. DiPersio Lab @DiPersioLab]

ASH! Using Jak-inhibitors to prevent #GvHD in patients. Low #CRS. Good anti-leukemic effect.
https://t.co/hYsJ7TctJ7

[John F. DiPersio Lab @DiPersioLab]

Indeed! Good news for our patients and scientists!

[Fehniger Lab @LabFehniger]

It's official! Wonderful news that we'll be expanding the BTCF/GMP to develop novel therapies, including cellular therapies! @WUSTLmed @SitemanCenter
School of Medicine to expand Lipstein BJC Institute of Health building https://t.co/t8kCUKFLJC via @wustlmed

[John F. DiPersio Lab @DiPersioLab]

Agree! Good team. Good work.

[Fehniger Lab @LabFehniger]

Congrats to Jeff Ward, Nancy Bartlett, and the whole @WUSTLmed @SitemanCenter team! Promising new combination for rel/ref DLBCL. Phase I/Dose Expansion Trial of Brentuximab vedotin/Lenalidomide in Relapsed or Refractory DLBCL #lymphoma https://t.co/WpbUxaJQsR

[John F. DiPersio Lab @DiPersioLab]

Also see the lay friendly in the WU Record: https://t.co/9CvuQ9w6Ws

[John F. DiPersio Lab @DiPersioLab]

Congrats, @PersaudSquad !
https://t.co/RgzcNoG2Uz

[Russell Pachynski @RPachynski]

The Pachynski Lab is looking to hire!
Leukocyte trafficking, tumor immunology, and basic/translational projects with a focus on prostate cancer.
Please RT!

https://t.co/NbRZi2kr83

#postdocjobs @PCF_Science @WUSTLdbbs @WUSTLImmuno @ACS_Research @WUSTLmed

[John F. DiPersio Lab @DiPersioLab]

Welcoming Jingyu Xiang to the lab today! Jerry has the distinction of publishing with us in September before he even joined! Welcome Jerry!

[John F. DiPersio Lab @DiPersioLab]

@PersaudSquad Brightened mine, too, Steve! Great news.

[John F. DiPersio Lab @DiPersioLab]

Wanted: level two technicians to work on immunological approaches to cure blood cancers (#myeloma #leukemia) at Washington University in St. Louis. General lab and animal handling experienced preferred. Email: [email protected] #sciencejobs #CARTcells

[John F. DiPersio Lab @DiPersioLab]

#CARTcell targeting CD7 could significantly decrease a patient’s immune function. Our recent preclinical work led by Dr. Miriam Kim shows that a transplant of hematopoietic stem cells with CD7 #CRISPR’d out could solve that problem. https://t.co/9CTZ3VAcpF

[John F. DiPersio Lab @DiPersioLab]

@DrawImpacts @aadel_chaudhuri @AngelaHirbe @jack_shern @ZacharySmithMD Lovely job once again.

[Russell Pachynski @RPachynski]

Amazing opportunities to develop cutting edge #neoantigen vaccine trials (@GavinGpdunn @LabFehniger @Pachynski_Lab @malachigriffith @chrisamiller), #ctdna studies (@aadel_chaudhuri @ChrisMaher_Lab) and novel #ProstateCancer treatments (@MReimersMD @uropro)!